(Q35538512)

8 August 2017

1 reference

title

Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in patients with chronic kidney diseases (English)

1 reference

8 August 2017

1 reference

Christian Fleck

1

1 reference

8 August 2017

Frank Schweitzer

2

1 reference

8 August 2017

Elke Karge

3

1 reference

8 August 2017

Martin Busch

4

1 reference

8 August 2017

Günter Stein

5

1 reference

8 August 2017

language of work or name

1 reference

1 October 2003

1 reference

8 August 2017

1 reference

8 August 2017

336

1 reference

8 August 2017

1-2

1 reference

8 August 2017

1-12

1 reference

Arginine availability, arginase, and the immune response

8 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Nitric oxide (NO) in renal physiology and pathophysiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Analysis of the mechanisms of human cytotoxic T lymphocyte response inhibition by NO.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Elevatedl-Arginine/Dimethylarginine Ratio Contributes to Enhanced Systemic NO Production by Dietaryl-Arginine in Hypercholesterolemic Rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Restoring vascular nitric oxide formation by l-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Asymmetric dimethylarginine, derangements of the endothelial nitric oxide synthase pathway, and cardiovascular diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

The heterodimeric amino acid transporter 4F2hc/y+LAT2 mediates arginine efflux in exchange with glutamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Interference of L-arginine analogues with L-arginine transport mediated by the y+ carrier hCAT-2B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Acute administration of L-arginine does not improve arterial endothelial function in chronic renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Nitric oxide and the pathogenesis of heart muscle disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Elevation of an endogenous inhibitor of nitric oxide synthesis in experimental congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Nitric oxide synthase inhibitors and hypertension in children and adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Vascular endothelial cell activation associated with increased plasma asymmetric dimethyl arginine in children and young adults with hypertension: a basis for atheroma?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Formation of free nitric oxide from l-arginine by nitric oxide synthase: direct enhancement of generation by superoxide dismutase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Renin-angiotensin system is involved in the mechanism of increased serum asymmetric dimethylarginine in essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Asymmetric dimethylarginine, blood pressure, and renal perfusion in elderly subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

ADMA (asymmetric dimethylarginine): an atherosclerotic disease mediating agent in patients with renal disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Detection of NG,NG-dimethylarginine dimethylaminohydrolase in human tissues using a monoclonal antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Biological significance of endogenous methylarginines that inhibit nitric oxide synthases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Difference between endothelium-dependent relaxation in arterial and in venous coronary bypass grafts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Metabolism of methylarginines by human vasculature; implications for the regulation of nitric oxide synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Concentration of dimethyl-L-arginine in the plasma of patients with end-stage renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Effects of guanidino and uremic compounds on nitric oxide pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Guanidino compounds in serum and urine of nondialyzed patients with chronic renal insufficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Nitric oxide synthase: Aspects concerning structure and catalysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Accumulated endogenous NOS inhibitors, decreased NOS activity, and impaired cavernosal relaxation with ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in experimental hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

The L-arginine-nitric oxide pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Effect of NG-monomethyl L-arginine on endothelium-dependent relaxation in arterioles of one-kidney, one clip hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Nitric oxide synthases: Roles, tolls, and controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Nitric oxide preferentially induces type 1 T cell differentiation by selectively up-regulating IL-12 receptor beta 2 expression via cGMP

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Net renal extraction of asymmetrical (ADMA) and symmetrical (SDMA) dimethylarginine in fasting humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Effects of NO donors and synthase agonists on endothelial cell uptake of L-Arg and superoxide production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Relationship between salt intake, nitric oxide and asymmetric dimethylarginine and its relevance to patients with end-stage renal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Plasma asymmetric dimethylarginine and hyperemic myocardial blood flow in young subjects with borderline hypertension or familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Synergism of nitric oxide and maturation signals on human dendritic cells occurs through a cyclic GMP-dependent pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Determination of dimethylated arginines in human plasma by high-performance liquid chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Amelioration by L-arginine of a dysfunctional arginine/nitric oxide pathway in diabetic endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Immunoregulatory effects of L-arginine and therapeutical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Role of endothelium-derived nitric oxide in the regulation of blood pressure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Column chromatography of amino acids with fluorescence detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Total nitric oxide production is low in patients with chronic renal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Biological roles of nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Plasma sulfur amino acids in relation to cardiovascular disease, nutritional status, and diabetes mellitus in patients with chronic renal failure at start of dialysis therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

L-arginine attenuates platelet reactivity in hypercholesterolemic rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Increased endogenous nitric oxide synthase inhibitor in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Human cationic amino acid transporter hCAT-3 is preferentially expressed in peripheral tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Dimethylarginines in chronic renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Cholesterol, endothelial function and cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Circulating endothelial nitric oxide synthase inhibitory factor in some patients with chronic renal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900338-3

10.1016/S0009-8981(03)00338-3

7 January 2021

Identifiers

DOI

1 reference

8 August 2017

1 reference